oxazolidin-2-one has been researched along with Alloxan Diabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chhibber, S; Kaur, T | 1 |
Morinet, F | 1 |
Bae, SK; Kim, WB; Kwon, JW; Lee, DC; Lee, MG; Lee, SJ; Yang, SH | 1 |
3 other study(ies) available for oxazolidin-2-one and Alloxan Diabetes
Article | Year |
---|---|
Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Diabetes Mellitus, Experimental; Diabetic Foot; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Staphylococcal Skin Infections; Treatment Outcome | 2013 |
[Bacteriophage therapy and diabetic foot ulcer].
Topics: Acetamides; Animals; Anti-Infective Agents; Bacteriophages; Combined Modality Therapy; Diabetes Mellitus, Experimental; Diabetic Foot; Humans; Linezolid; Mice; Mice, Inbred BALB C; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Superinfection | 2013 |
Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
Topics: Administration, Oral; Animals; Area Under Curve; Diabetes Mellitus, Experimental; Injections, Intravenous; Male; Metabolic Clearance Rate; Oxazolidinones; Rats; Rats, Sprague-Dawley; Streptozocin; Time Factors | 2005 |